Schizophrenia trials in Greece
4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Where
- Athens, Chaïdári, Heraklion, Kifissia, Thessaloniki
- Age
- 55 years to 90 years
- People
- 406 worldwide
- Run by
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT06585787 · EU 2024-516363-92-00 - Phase 3Taking peopleStratification and Treatment in Early Psychosis Study - ENHANCE
- Where
- Athens
- Age
- 16 years to 40 years
- People
- 250 worldwide
- Run by
- University of Oxford
See details and how to joinNCT06778564 · EU 2025-521929-32-00 - Phase 3Not yet taking people in GreeceStratification and Treatment in Early Psychosis Study -ASSIST
- Where
- Athens
- Age
- 16 years to 50 years
- People
- 250 worldwide
- Run by
- University of Oxford
See details and how to joinNCT07326124 - Phase 3Not yet taking people in GreeceStratification and Treatment in Early Psychosis Study - PROMOTE
- Where
- Athens
- Age
- 12 years to 35 years
- People
- 586 worldwide
- Run by
- University of Oxford
See details and how to joinNCT07434973